Related Experiment Videos
Bioinformatics analysis of gene expression alterations in microRNA‑122 knockout mice with hepatocellular carcinoma
Bosheng He1, Ying He2, Weixiang Shi1
1Department of Radiology, The Second Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, P.R. China.
Abstract:
Reduced microRNA (miR)‑122 expression levels are frequently observed in hepatocellular carcinoma (HCC). The present study was conducted to investigate potential targets of miR‑122 and determine the underlying regulatory mechanisms of miR‑122 in HCC development. The public dataset GSE31731 was utilized, consisting of 8 miR‑122 knockout (KO) mice (miR‑122 KO) and 8 age‑matched wild‑type mice (WT group). Following data preprocessing, the differentially expressed genes (DEGs) were selected, followed by enrichment analysis. A protein‑protein interaction (PPI) network was established, and a module network was further extracted. Combining the DEGs with microRNA targeting databases permitted the screening of the overlapping targets of miR‑122. Furthermore, previously reported genes were screened out by literature mining. Transcription factors (TFs) of the targets were subsequently investigated. DEGs between miR‑122 KO and WT groups were selected, including 713 upregulated and 395 downregulated genes. Of these, upregulated genes were enriched in cell cycle‑associated processes [including nucleolar and spindle associated protein 1 (NUSAP1)], the cytokine‑cytokine receptor interaction pathway [including C‑X‑C motif chemokine receptor 4 (CXCR4) and C‑C motif chemokine receptor 2 (CCR2)], and the extracellular matrix‑receptor interaction pathway [including integrin subunit alpha V (ITGAV)]. In addition, multiple overlapping targets were highlighted in the PPI network, including NUSAP1, CXCR4, CCR2 and ITGAV. Notably, CXCR4 and CCR2 were linked in module C, enriched in the cytokine‑cytokine receptor interaction pathway. Furthermore, upregulated sex determining region Y‑box 4 (SOX4) was identified as a TF. The results of the present study may provide a theoretical basis for further studies on the mechanisms of miR‑122 in the development of HCC.
Insights
MicroRNA-122 (miR-122) loss in hepatocellular carcinoma (HCC) impacts cell cycle and cytokine pathways. This study identifies key targets like NUSAP1, CXCR4, and CCR2, revealing miR-122
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Reduced microRNA (miR)-122 expression is common in hepatocellular carcinoma (HCC).
- Understanding miR-122's regulatory role is crucial for HCC pathogenesis.
- Identifying miR-122 targets can elucidate its function in liver cancer.
Purpose of the Study:
- To investigate potential targets of miR-122 in HCC.
- To determine the regulatory mechanisms of miR-122 in HCC development.
- To identify key genes and pathways affected by miR-122 deficiency.
Main Methods:
- Utilized public dataset GSE31731 from miR-122 knockout (KO) and wild-type (WT) mice.
- Performed differential gene expression (DEG) analysis.
- Constructed protein-protein interaction (PPI) and module networks.
- Integrated DEGs with microRNA targeting databases and literature mining.
- Investigated transcription factors (TFs) of identified targets.
Main Results:
- Identified 713 upregulated and 395 downregulated DEGs between miR-122 KO and WT groups.
- Upregulated genes were enriched in cell cycle, cytokine-cytokine receptor interaction, and extracellular matrix-receptor interaction pathways.
- Key overlapping targets including NUSAP1, CXCR4, CCR2, and ITGAV were highlighted in the PPI network.
- CXCR4 and CCR2 formed a module enriched in cytokine-cytokine receptor interaction.
- Upregulated SOX4 was identified as a transcription factor.
Conclusions:
- miR-122 deficiency in HCC is associated with dysregulation of cell cycle and cytokine signaling pathways.
- NUSAP1, CXCR4, CCR2, and ITGAV are potential direct or indirect targets of miR-122.
- SOX4 may play a role in regulating miR-122 targets in HCC.
- Findings provide a theoretical basis for further research into miR-122's role in HCC development.